These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 39055490)

  • 1. Hyaluronic acid-modified liposomes Potentiated
    Sun X; He Z; Lu R; Liu Z; Chiampanichayakul S; Anuchapreeda S; Jiang J; Tima S; Zhong Z
    Front Pharmacol; 2024; 15():1437515. PubMed ID: 39055490
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of growth and metastasis of breast cancer by targeted delivery of 17-hydroxy-jolkinolide B via hyaluronic acid-coated liposomes.
    Liu D; Zhang Q; Wang J; Guan S; Cai D; Liu J
    Carbohydr Polym; 2021 Apr; 257():117572. PubMed ID: 33541631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transferrin-Modified Triptolide Liposome Targeting Enhances Anti-Hepatocellular Carcinoma Effects.
    Zhao X; Yang Y; Su X; Xie Y; Liang Y; Zhou T; Wu Y; Di L
    Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamic evaluation of hyaluronic acid-modified imatinib-loaded PEGylated liposomes in CD44-positive Gist882 tumor-bearing mice.
    Huang J; Chen J
    J Liposome Res; 2024 Mar; 34(1):97-112. PubMed ID: 37401372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylated hyaluronic acid-coated liposome for enhanced in vivo efficacy of sorafenib via active tumor cell targeting and prolonged systemic exposure.
    Mo L; Song JG; Lee H; Zhao M; Kim HY; Lee YJ; Ko HW; Han HK
    Nanomedicine; 2018 Feb; 14(2):557-567. PubMed ID: 29248675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
    Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
    Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
    [No Abstract]   [Full Text] [Related]  

  • 7. HA-DOPE-Modified Honokiol-Loaded Liposomes Targeted Therapy for Osteosarcoma.
    Zhang X; Chen H; Zhang Y; Huang Q; Feng J; Xing H; Fu X; Yan X; Zhang Y; Xu Q; Liang J
    Int J Nanomedicine; 2022; 17():5137-5151. PubMed ID: 36345507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells.
    Taetz S; Bochot A; Surace C; Arpicco S; Renoir JM; Schaefer UF; Marsaud V; Kerdine-Roemer S; Lehr CM; Fattal E
    Oligonucleotides; 2009 Jun; 19(2):103-16. PubMed ID: 19374532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
    Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
    Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic Acid Coating Reduces the Leakage of Melittin Encapsulated in Liposomes and Increases Targeted Delivery to Melanoma Cells.
    Li Y; Ruan S; Wang Z; Feng N; Zhang Y
    Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A stabilized retro-inverso peptide ligand of transferrin receptor for enhanced liposome-based hepatocellular carcinoma-targeted drug delivery.
    Tang J; Wang Q; Yu Q; Qiu Y; Mei L; Wan D; Wang X; Li M; He Q
    Acta Biomater; 2019 Jan; 83():379-389. PubMed ID: 30395963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery.
    Yang Y; Zhao Y; Lan J; Kang Y; Zhang T; Ding Y; Zhang X; Lu L
    Int J Nanomedicine; 2018; 13():4361-4378. PubMed ID: 30100720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial targeted hierarchical drug delivery system based on HA-modified liposomes for cancer therapy.
    Chen H; Fang Z; Song M; Liu K
    Eur J Med Chem; 2022 Nov; 241():114648. PubMed ID: 35963128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronic acid-modified liposomal honokiol nanocarrier: Enhance anti-metastasis and antitumor efficacy against breast cancer.
    Wang J; Liu D; Guan S; Zhu W; Fan L; Zhang Q; Cai D
    Carbohydr Polym; 2020 May; 235():115981. PubMed ID: 32122511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
    Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
    J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coadministration of Oligomeric Hyaluronic Acid-Modified Liposomes with Tumor-Penetrating Peptide-iRGD Enhances the Antitumor Efficacy of Doxorubicin against Melanoma.
    Deng C; Zhang Q; Fu Y; Sun X; Gong T; Zhang Z
    ACS Appl Mater Interfaces; 2017 Jan; 9(2):1280-1292. PubMed ID: 28009503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models.
    Chi Y; Yin X; Sun K; Feng S; Liu J; Chen D; Guo C; Wu Z
    J Control Release; 2017 Sep; 261():113-125. PubMed ID: 28666726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic Acid Coated Liposomes Co-Delivery of Natural Cyclic Peptide RA-XII and Mitochondrial Targeted Photosensitizer for Highly Selective Precise Combined Treatment of Colon Cancer.
    Xu Y; Yao Y; Wang L; Chen H; Tan N
    Int J Nanomedicine; 2021; 16():4929-4942. PubMed ID: 34326635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation, development and evaluation of hyaluronic acid-conjugated liposomal nanoparticles loaded with regorafenib and curcumin and their in vitro evaluation on colorectal cancer cell lines.
    Shnaikat SG; Shakya AK; Bardaweel SK
    Saudi Pharm J; 2024 Jul; 32(7):102099. PubMed ID: 38817822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phytosterol-loaded CD44 receptor-targeted PEGylated nano-hybrid phyto-liposomes for synergistic chemotherapy.
    Gautam M; Thapa RK; Gupta B; Soe ZC; Ou W; Poudel K; Jin SG; Choi HG; Yong CS; Kim JO
    Expert Opin Drug Deliv; 2020 Mar; 17(3):423-434. PubMed ID: 32028805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.